What do we know about nutrient-based strategies targeting molecular mechanisms associated with obesity-related fatty liver disease? Ingrid Rivera-Iñiguez; Arturo Panduro; Sonia Roman; Karina González-Aldaco;

Body mass index and diabetes predict severity of liver fibrosis across the spectrum of steatotic liver disease Eda Kaya; Eduardo Vilar-Gomez; Raj Vuppalanchi; Yusuf Yilmaz;

Natural history and outcomes of MASLD and MetALD following non-alcoholic fatty liver disease reclassification in a Canadian cohort Yousef Almahanna; Francisco Idalsoaga; Luis Antonio Díaz; Ahmed Almohsen; Yi Nong Song; Amani Bajunayd; Rokhsana Mortuza; Jeemin Kim; Adrienne Abaya; Mohammad Qasim Khan; Juan Pablo Arab;